Location History:
- Toyama, JA (1976)
- Uozu, JA (1978)
- Toyama, JP (1986)
Company Filing History:
Years Active: 1976-1986
Title: Takuya Kodama: Innovator in Pharmaceutical Chemistry
Introduction
Takuya Kodama is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, his work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Kodama's latest patents include a novel N-acyl acidic amino acid diamide derivative, which has demonstrated anti-ulcer activity effective for both humans and animals. This compound is represented by a specific general formula, where various groups can be substituted to enhance its efficacy. Additionally, he has developed a 2-[4-(3-oxo- or hydroxy-alkyl)phenyl]alkanoic acid and its non-toxic salts, which are useful for alleviating symptoms of inflammation and pain in mammals, including humans. These inventions highlight his commitment to advancing medical treatments through innovative chemical compounds.
Career Highlights
Takuya Kodama is associated with Toyama Chemical Co., Ltd., where he has been instrumental in research and development. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry. His dedication to innovation is evident in the practical applications of his inventions.
Collaborations
Kodama has collaborated with notable colleagues such as Noboru Takagawa and Yasuyuki Suzuki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new pharmaceutical solutions.
Conclusion
Takuya Kodama's contributions to pharmaceutical chemistry through his innovative patents demonstrate his expertise and commitment to improving health outcomes. His work continues to influence the field and offers promising solutions for various medical challenges.